Why Europe's pharma giants could be insulated from Trump's 100% drug tariffs

CNBC's Silvia Amaro looks at how investors around the world are digesting news of President Donald Trump's 100% tariff on branded drugs, and whether Europe's pharma giants will avoid the worst impact.